Introduction: Limited evidence exists on the cost-effectiveness of interventions to prevent obesity and promote healthy body image in adolescents. The SHINE (Supporting Healthy Image, Nutrition and Exercise) study is a cluster randomised control trial (cRCT) aiming to deliver universal education about healthy nutrition and physical activity to adolescents, as well as targeted advice to young people with body image concerns who are at risk of developing disordered eating behaviours. This paper describes the methods for the economic evaluation of the SHINE cRCT, to determine whether the intervention is cost-effective as an obesity prevention measure.

Methods And Analysis: A public payer perspective will be adopted, with intervention costs collected prospectively. Within-trial cost-effectiveness analysis (CEA) and cost-utility analysis (CUA) will quantify the incremental costs and health gains of the intervention as compared with usual practice (ie, teacher-delivered curriculum). CEA will present results as cost per body mass index unit saved. CUA will present results as cost per quality-adjusted life year gained. A modelled CUA will extend the target population, time horizon and decision context to provide valuable information to policymakers on the potential for incremental cost offsets attributable to disease prevention arising from intervention. Intervention costs and effects will be extrapolated to the population of Australian adolescents in Grade 7 of secondary school (approximate age 13 years) and modelled over the cohort's lifetime. Modelled CUA results will be presented as health-adjusted life years saved and healthcare cost-savings of diseases averted. Incremental cost-effectiveness ratios will be calculated as the difference in costs between the intervention and comparator divided by the difference in benefit. Semi-structured interviews with key intervention stakeholders will explore the potential impact of scalability on cost-effectiveness. These data will be thematically analysed to inform sensitivity analysis of the base case economic evaluation, such that cost-effectiveness evidence is reflective of the potential for scalability.

Ethics And Dissemination: Ethics approval was obtained from the Deakin University Human Research Ethics Committee (#2017-269) and the Victorian Department of Education and Training (#2018_003630). Study findings will be disseminated through peer-reviewed academic papers and participating schools will receive annual reports over the 3 years of data collection.

Trial Registration Number: ACTRN 12618000330246; Pre-results.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402000PMC
http://dx.doi.org/10.1136/bmjopen-2020-038050DOI Listing

Publication Analysis

Top Keywords

cua will
16
economic evaluation
12
will
12
shine supporting
8
supporting healthy
8
healthy image
8
image nutrition
8
nutrition exercise
8
cluster randomised
8
body image
8

Similar Publications

A long-term analysis, modeling and drivers of forest recovery in Central Mexico.

Environ Monit Assess

December 2024

Instituto de Geografía, Universidad Nacional Autónoma de México, Ciudad Universitaria, C.P. 04510, Coyoacán, Mexico City, Mexico.

This study aims to evaluate the changes in forest cover from 1994 to 2015, identify the key drivers of forest recovery, and predict future trends. Using high-resolution remote sensing data, we mapped forest canopy density into detailed categories (closed > 50%, open 10-50%, and deforested < 10%) to differentiate processes like degradation, deforestation, densification, reforestation, and afforestation. A multinomial logistic regression was used to explore the relationship between the forest processes and socioeconomic, proximity, planning, and policy potential drivers.

View Article and Find Full Text PDF

Background And Aim: We aim to identify within-trial and modelled Cost-Utility Analysis (CUA) in substance use disorders (SUD) and review the applicability assessment associated with health utility used in modelled CUA.

Study Design And Methods: We searched Medline, Embase, EconLit and the Pharmaceutical Benefits Advisory Committee (PBAC) databases. A global systematic literature search was undertaken to determine the CUA of SUD interventions.

View Article and Find Full Text PDF

c-MYC is overexpressed in 70% of human cancers, including triple-negative breast cancer (TNBC), yet there is no clinically approved drug that directly targets it. Here, we engineered the mRNA-stabilizing poly U sequences within the 3'UTR of c-MYC to specifically destabilize and promote the degradation of c-MYC transcripts. Interestingly, the engineered derivative outcompetes the endogenous overexpressed c-MYC mRNA, leading to reduced c-MYC mRNA and protein levels.

View Article and Find Full Text PDF

Background: With the implementation of the 11th edition of the International Classification of Diseases (ICD-11) and the publication of the metabolic dysfunction-associated fatty liver disease (MAFLD) nomenclature in 2020, it is important to establish consensus for the coding of MAFLD in ICD-11. This will inform subsequent revisions of ICD-11.

Methods: Using the Qualtrics XM and WJX platforms, questionnaires were sent online to MAFLD-ICD-11 coding collaborators, authors of papers, and relevant association members.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!